Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Molecular Imaging of Breast Cancer I

  • You have access
    Can 18F-fluoroestradiol PET/CT demonstrate the heterogeneity of breast cancer in vivo?
    Zhongyi Yang and Yingjian Zhang
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 15;
  • You have access
    Comparison of radio-guided occult lesion localization (ROLL) and wire guided localization (WGL) methods for the preoperative localization of non-palpable breast lesions
    Nazim Kanat, Meltem Caglar, Murat Tuncel and Biray Caner
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 17;
  • You have access
    Assessment of early therapy response with [18F]FLT PET images in breast cancer patients
    Mattia Veronese, Gaia Rizzo, Eric Aboagye and Alessandra Bertoldo
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 21;
  • You have access
    [99mTc]Tilmanocept identifies more positive nodes using fewer sentinel lymph nodes compared to [99mTc] sulfur colloid in early stage breast cancer patients
    Jennifer Baker, Minya Pu, Karen Messer, Christopher Tokin, Carl Hoh, David Vera and Anne Wallace
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 16;
  • You have access
    FES PET biomarkers to predict benefit from endocrine therapy
    Brenda Kurland, Lanell Peterson, Hannah Linden, Jean Lee, Erin Schubert, Jeanne Link, Janet Eary, Kenneth Krohn and David Mankoff
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 19;
  • You have access
    Staging the axillae in breast cancer patients with 18F-FDG PET/CT: How small are the metastases that we can detect with new generation clinical PET/CT?
    Dimitri Bellevre, Cécile Blanc-Fournier, Christelle Levy, Djelila Allouache, Renaud Ciappuccini, Stéphane Bardet and Nicolas Aide
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 18;
  • You have access
    Can PET/CT with the dual tracers 18F-FDG and 18F-FES predict neoadjuvant chemotherapy response of breast cancer? A pilot study
    Zhongyi Yang and Yingjian Zhang
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 20;
SNMMI

© 2025 SNMMI

Powered by HighWire